[UOADEV] QoQ TTM Result on 30-Sep-2015 [#3]

Stock
[UOADEV] UOA DEVELOPMENT BERHAD
Announcement Date
23-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 16.43%
YoY- 24.68%
Quarter Report
Latest QR
Upcoming QR
UOADEV's Result
UOADEV's Financial Summary
View:
Show?
TTM Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 1,499,756 1,530,659 1,643,188 1,465,341 1,323,017 1,216,564 1,077,849 24.66%
PBT 729,579 656,507 645,286 586,585 518,662 512,835 460,704 35.90%
Tax -172,216 -161,206 -157,253 -144,644 -124,090 -116,051 -103,864 40.13%
NP 557,363 495,301 488,033 441,941 394,572 396,784 356,840 34.65%
-
NP to SH 489,908 434,612 417,016 394,351 338,696 349,954 316,122 33.95%
-
Tax Rate 23.60% 24.56% 24.37% 24.66% 23.93% 22.63% 22.54% -
Total Cost 942,393 1,035,358 1,155,155 1,023,400 928,445 819,780 721,009 19.56%
-
Net Worth 3,147,438 3,253,274 3,145,125 3,014,030 2,717,118 2,835,663 2,746,469 9.51%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 227,907 227,907 227,907 185,958 185,958 185,958 185,958 14.53%
Div Payout % 46.52% 52.44% 54.65% 47.16% 54.90% 53.14% 58.83% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 3,147,438 3,253,274 3,145,125 3,014,030 2,717,118 2,835,663 2,746,469 9.51%
NOSH 1,520,501 1,520,221 1,519,384 1,507,015 1,430,062 1,432,153 1,430,453 4.15%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 37.16% 32.36% 29.70% 30.16% 29.82% 32.62% 33.11% -
ROE 15.57% 13.36% 13.26% 13.08% 12.47% 12.34% 11.51% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 98.64 100.69 108.15 97.23 92.51 84.95 75.35 19.68%
EPS 32.22 28.59 27.45 26.17 23.68 24.44 22.10 28.60%
DPS 15.00 14.99 15.00 12.34 13.00 12.98 13.00 10.01%
NAPS 2.07 2.14 2.07 2.00 1.90 1.98 1.92 5.14%
Adjusted Per Share Value based on latest NOSH - 1,507,015
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 60.19 61.43 65.95 58.81 53.10 48.83 43.26 24.65%
EPS 19.66 17.44 16.74 15.83 13.59 14.05 12.69 33.92%
DPS 9.15 9.15 9.15 7.46 7.46 7.46 7.46 14.59%
NAPS 1.2632 1.3057 1.2623 1.2097 1.0905 1.1381 1.1023 9.51%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 2.19 2.12 2.06 1.92 2.10 2.21 2.11 -
P/RPS 2.22 2.11 1.90 1.97 2.27 2.60 2.80 -14.34%
P/EPS 6.80 7.42 7.51 7.34 8.87 9.04 9.55 -20.27%
EY 14.71 13.49 13.32 13.63 11.28 11.06 10.47 25.46%
DY 6.85 7.07 7.28 6.43 6.19 5.88 6.16 7.34%
P/NAPS 1.06 0.99 1.00 0.96 1.11 1.12 1.10 -2.44%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 24/08/16 25/05/16 25/02/16 23/11/15 20/08/15 27/05/15 25/02/15 -
Price 2.39 2.21 2.10 2.12 1.82 2.25 2.12 -
P/RPS 2.42 2.19 1.94 2.18 1.97 2.65 2.81 -9.48%
P/EPS 7.42 7.73 7.65 8.10 7.68 9.21 9.59 -15.73%
EY 13.48 12.94 13.07 12.34 13.01 10.86 10.42 18.74%
DY 6.28 6.78 7.14 5.82 7.14 5.77 6.13 1.62%
P/NAPS 1.15 1.03 1.01 1.06 0.96 1.14 1.10 3.01%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment